November 2024 - QuartzBio

Interoperability in Precision Medicine: What does it mean?

In modern drug development, connectedness is crucial for success, especially in remote and decentralized teams. This connectedness involves linking people and information to extract shared insights from data and make faster decisions.

In practice, this means ensuring interoperability of data, technology, systems, and ecosystems through a scalable, modular data fabric architecture. It connects various data sources, including enterprise data lakes, biomarker data, sample data, clinical sites, real-world information, and public databases, to create a robust data and insights supply chain (Figure 1, below).

Interoperability in Precision Medicine: Why does it matter?

Interoperability is vital for precision medicine as it enables seamless integration of applications and workflows for data analysis, storage, and processing. This reduces human intervention, minimizes variability, and enhances data reproducibility.

The Data-Value Gap: Only 32% of companies have reported being able to extract business value from their data, and only 27% have described the output of data and analytics projects as being “highly actionable.”
Interoperability of systems and technologies closes this gap.

By employing FAIR (Findability, Accessibility, Interoperability, and Reusability) principles, organizations can close the “data-value gap” and increase the quality, accessibility, and usability of their data.

QuartzBio’s Approach to Interoperability

QuartzBio’s Biomarker Intelligence Platform uses a fully interoperable, scalable, and modular data fabric solution to maintain connectivity with all data streams across complex technology and vendor ecosystems generated by R&D programs. This platform supports cross-ecosystem interoperability and generates insights using business intelligence tools.

QuartzBio’s approach drives value for multiple teams by unifying point solutions and enabling sample and biomarker insights to flow freely between operations teams, translational researchers, data science/bioinformatics teams, and business executives, thus powering decision-making for day-to-day use cases.

By creating a data fabric architecture to ingest and harmonize data and technologies spanning across this complex ecosystem, QuartzBio’s Biomarker Intelligence Platform can serve as either a standalone enterprise system supporting Precision Medicine, or a robust system that can integrate seamlessly and serve domain-specific functions in the context of the broader drug ecosystem.

QuartzBio’s approach drives value for multiple teams by unifying point solutions and enabling sample and biomarker insights to flow freely between operations teams, translational researchers, data science/bioinformatics teams, and business executives, thus powering decision-making for day-to-day use cases.

By creating a data fabric architecture to ingest and harmonize data and technologies spanning across this complex ecosystem, QuartzBio’s Biomarker Intelligence Platform can serve as either a standalone enterprise system supporting Precision Medicine, or a robust system that can integrate seamlessly and serve domain-specific functions in the context of the broader drug ecosystem.

The Opportunity: Closing the Data-Value Gap

As sponsors invest more and more resources in generating data as part of clinical programs, there is increasing pressure to close the data-value gap. Because QuartzBio’s platform is built to be fully interoperable with clients’ systems and applications, clients can recognize immediate value across multiple functions across their enterprise.

CONTACT US TO CONTINUE THE CONVERSATION

Figure 1. A typical Precision Medicine Ecosystem and how QuartzBio’s Biomarker Intelligence Platform fits within it, providing data fabric architecture tailored for Precision Medicine.

February 3-6, 2025 | Orlando, FL, USA

If your team tackles sample management and/or biomarker operations, don’t miss this year’s SCOPE (Summit for Clinical Operations Executives) conference in Orlando! QuartzBio will be presenting

“From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI”
12:35 PM, Tuesday, February 4, Modernizing Lab, Biomarker & Data Management Operations track

We’ll demonstrate how you can use QuartzBio’s AI-enabled platform to ask questions, get answers, and gain insights across the entire precision medicine data ecosystem, with real-time sample intelligence from point of collection to data generation.

Want to explore our sample intelligence solution in person?

Submit the contact form to book a 1:1 at our booth for a personalized demo experience:

Schedule a demo with our team

“We have not seen anything like [QuartzBio] and it has the power to unlock this data for a variety of our stakeholders, such as medical directors and translational scientists, which is exciting.”

“QuartzBio’s reporting is very helpful. From an Operations perspective, it helps us identify sites that may be missing collections so we can have the study’s CRO mitigate”.

“The [QuartzBio] platform is a good investment. Think about the turnover. The platform allows continuity for programs, nothing is lost in transitions. Very valuable as central repository of data. When people leave companies – and they have been massaging the data – the data is basically lost – I have no idea where to find it.”